Vossloh AG:企業の戦略・SWOT・財務情報

◆英語タイトル:Vossloh AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3781
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vossloh AG – Strategy, SWOT and Corporate Finance Report
Summary

Vossloh AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vossloh AG (Vossloh), is a rail infrastructure company. The company specializes in providing transport technology for rail infrastructure and technology markets. The company manufactures rail fasteners; rail switch, actuating and monitoring systems. In addition, it also provides production, maintenance and shipment of long rails along reconditioning and recycling of old rails. Moreover, Vossloh offers diesel locomotives along with maintenance and leasing services to urban and suburban trains for a variety of operations. The company also develops and manufactures key electrical components and systems for light rail vehicles. The company has its operations in Europe, America, Asia, Africa and Australia. Vossloh is headquartered in Werdohl, Germany.

Scope

- Detailed information on Vossloh AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vossloh AG in the form of a SWOT analysis
- An in-depth view of the business model of Vossloh AG including a breakdown and examination of key business segments
- Intelligence on Vossloh AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vossloh AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vossloh AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vossloh AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vossloh AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vossloh AG: Company Overview 9
Vossloh AG: Overview and Key Facts 9
Vossloh AG: Overview 9
Vossloh AG: Key Facts 9
Vossloh AG: Key Employees 11
Vossloh AG: Key Employee Biographies 12
Vossloh AG: Major Products and Services 13
Vossloh AG: Company History 14
Vossloh AG: Management Statement 18
Vossloh AG: Locations and Subsidiaries 20
Vossloh AG: Key Competitors 22
Vossloh AG: Company Analysis 23
Vossloh AG: Business Description 23
Vossloh AG: SWOT Analysis 24
Vossloh AG: SWOT Overview 24
Vossloh AG: Strengths 24
Vossloh AG: Weaknesses 25
Vossloh AG: Opportunities 25
Vossloh AG: Threats 26
Vossloh AG: Corporate Financial Deals Activity 27
Vossloh AG: Financial Deals Overview 27
Vossloh AG: Targets and Partners 29
Vossloh AG: Top Deals 2014 – 2018YTD* 30
Vossloh AG: Mergers and Acquisitions 31
Vossloh AG: Partnership 32
Vossloh AG: Divestments 33
Vossloh AG: Recent Developments 34
Vossloh AG: News and Events Summary 34
Vossloh AG: Business Reorganization 35
Vossloh AG: Contracts 35
Vossloh AG: Corporate Governance 36
Vossloh AG: Financial Performance 37
Vossloh AG: Strategy and Operations 37
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: Vossloh AG: Key Facts
Table 2: Vossloh AG: Key Employees
Table 3: Vossloh AG: Locations and Subsidiaries
Table 4: Vossloh AG: Key Competitors
Table 5: Vossloh AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vossloh AG: M&A Activity by Geography (TTM*)
Table 7: Vossloh AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Vossloh AG: M&A Average Deal Size - Value (US$m)
Table 9: Vossloh AG: Targets and Partners
Table 10: Vossloh AG: Top Deals 2014 - 2018YTD*
Table 11: Vossloh AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Vossloh AG: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Vossloh AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Vossloh AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Vossloh AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Vossloh AG: Divestments by Geography (2014 - YTD*2018)
Table 17: Vossloh AG: News and Events Summary
Table 18: Vossloh AG: Business Reorganization
Table 19: Vossloh AG: Contracts
Table 20: Vossloh AG: Corporate Governance
Table 21: Vossloh AG: Financial Performance
Table 22: Vossloh AG: Strategy and Operations

List of Figures
Figure 1: Vossloh AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vossloh AG: M&A Activity by Geography (TTM*)
Figure 3: Vossloh AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Vossloh AG: M&A Average Deal Size - Value (US$m)
Figure 5: Vossloh AG: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Vossloh AG: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Vossloh AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Vossloh AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Vossloh AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Vossloh AG: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Vossloh AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teva Pharmaceutical Industries Ltd (TEVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Genor BioPharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Genor BioPharma Co Ltd (Genor) a subsidiary of Walvax Biotechnology Co Ltd is a bio-pharmaceutical company which develops and commercializes therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins and recombinant therapeutic proteins. Its service offerings include process and assay deve …
  • Broadspectrum (Australia) Pty Ltd:企業の戦略的SWOT分析
    Broadspectrum (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Parkway Properties Inc:企業のM&A・事業提携・投資動向
    Parkway Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Parkway Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • The Alfred Mann Foundation:製品パイプライン分析
    Summary The Alfred Mann Foundation (AMF) is a medical instutute that develops medical devices and commercializes solutions for significant medical conditions. The institute conducts research in the therapeutic areas of neuromuscular disorders, diabetes, limb loss, and chronic pain. It provides neuro …
  • Penta-Ocean Construction Co Ltd:企業の戦略・SWOT・財務分析
    Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • George Weston Limited:企業の戦略・SWOT・財務情報
    George Weston Limited - Strategy, SWOT and Corporate Finance Report Summary George Weston Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tomey Corporation:企業の戦略的SWOT分析
    Tomey Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Entasis Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Entasis Therapeutics Inc (Entasis) is a drug development company that discovers and develops anti-infective therapies for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, ETX0282, ETX0914 and Zoliflodacin. Its ETX2514 is a potent inhibitor of class A, C, …
  • Parker Hannifin Corp (PH):石油・ガス:M&Aディール及び事業提携情報
    Summary Parker Hannifin Corp (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions, including fluid power systems, electromechanical controls and related components. Its products find use in various industries and applicat …
  • Akamai Technologies Inc (AKAM):企業の財務・戦略的SWOT分析
    Akamai Technologies Inc (AKAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ferring Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferring Pharmaceuticals Inc (Ferring), a subsidiary of Ferring International Center SA is a biopharmaceutical company that conducts research and development services. The company develops peptide-based drugs and biotechnology derived medicines. It also develops effective and patient-friendly …
  • Best Doctors Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Best Doctors Inc (Best Doctors), a subsidiary of Teladoc, Inc, is a healthcare service provider that offers medical services. The company provides services such as inter-consultation and critical care inter-consultation services for multi-trauma, spinal cord injuries, traumatic brain injurie …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • Affymetrix, Inc.-医療機器分野:企業M&A・提携分析
    Summary Affymetrix, Inc. (Affymetrix) provides life science, and molecular diagnostic products for analysis of biological systems at gene, protein and cellular level. It offers products for two major applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument …
  • Astellas Pharma Inc (4503):企業の財務・戦略的SWOT分析
    Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Molnlycke Health Care AB:医療機器:M&Aディール及び事業提携情報
    Summary Molnlycke Health Care AB (Molnlycke), a subsidiary of Investor AB, is a medical device company. The company manufactures and markets single-use surgical and wound care products. It offers a range of surgical and wound care products; infection prevention solutions; prevention and treatment so …
  • Chinook Energy Inc (CKE):石油・ガス:M&Aディール及び事業提携情報
    Summary Chinook Energy Inc (Chinook) is an oil and gas company that offers exploration, development and production of oil and gas properties in Western Canada. The company explores and develops crude oil, natural gas liquids and natural gas. It develops inventory from the BBT Concession, exploration …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆